Back to Search
Start Over
Anti-Inflammatory Effects of Ang-(1-7) in Ameliorating HFD-Induced Renal Injury through LDLr-SREBP2-SCAP Pathway.
- Source :
-
PloS one [PLoS One] 2015 Aug 20; Vol. 10 (8), pp. e0136187. Date of Electronic Publication: 2015 Aug 20 (Print Publication: 2015). - Publication Year :
- 2015
-
Abstract
- The angiotensin converting enzyme 2-angiotensin-(1-7)-Mas axis (ACE2-Ang-(1-7)-Mas axis) is reported to participate in lipid metabolism in kidney, but its precise effects and underlying mechanisms remain unknown. We hypothesized that Ang-(1-7) reduces lipid accumulation and improves renal injury through the low density lipoprotein receptor-sterol regulatory element binding proteins 2-SREBP cleavage activating protein (LDLr-SREBP2-SCAP) system by suppressing inflammation in high fat diet (HFD)-fed mice. In this study, male C57BL/6 mice were randomized into four groups: STD (standard diet)+saline, HFD+saline, HFD+Ang-(1-7) and STD+Ang-(1-7). After 10 weeks of feeding, mice were administered Ang-(1-7) or saline for two weeks. We found that high inflammation status induced by HFD disrupted the LDLr-SREBP2-SCAP feedback system. Treatment of mice fed a high-fat diet with Ang-(1-7) induced significant improvement in inflammatory status, following the downregulation of LDLr, SREBP2 and SCAP, and then, decreased lipid deposition in kidney and improved renal injury. In conclusion, the anti-inflammatory effect of Ang-(1-7) alleviates renal injury triggered by lipid metabolic disorders through a LDLr- SREBP2-SCAP pathway.
- Subjects :
- Acute Kidney Injury etiology
Acute Kidney Injury immunology
Acute Kidney Injury pathology
Angiotensin I pharmacology
Animals
Anti-Inflammatory Agents pharmacology
Dyslipidemias drug therapy
Dyslipidemias etiology
Dyslipidemias immunology
Dyslipidemias pathology
Inflammation drug therapy
Inflammation etiology
Inflammation immunology
Inflammation pathology
Kidney drug effects
Kidney immunology
Kidney pathology
Lipid Metabolism drug effects
Male
Mice, Inbred C57BL
Peptide Fragments pharmacology
Signal Transduction drug effects
Acute Kidney Injury drug therapy
Angiotensin I therapeutic use
Anti-Inflammatory Agents therapeutic use
Diet, High-Fat adverse effects
Peptide Fragments therapeutic use
Receptors, LDL immunology
Sterol Regulatory Element Binding Protein 2 immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1932-6203
- Volume :
- 10
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- PloS one
- Publication Type :
- Academic Journal
- Accession number :
- 26291618
- Full Text :
- https://doi.org/10.1371/journal.pone.0136187